Disease severity and mortality can be independently regulated in a mouse model of experimental graft versus host disease.
Graft versus host disease (GVHD) is the major limitation of allogeneic hematopoietic stem cell transplantation (HSCT) presenting high mortality and morbidity rates. However, the exact cause of death is not completely understood and does not correlate with specific clinical and histological parameter...
Main Authors: | Rômulo G Galvani, Ramon Lemos, Rômulo B Areal, Pollyanna A Salvador, Dario S Zamboni, João Luiz M Wanderley, Adriana Bonomo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4313938?pdf=render |
Similar Items
-
Mouse models of graft-versus-host disease: advances and limitations
by: Mark A. Schroeder, et al.
Published: (2011-05-01) -
Can Graft vs. Leukemia Effect Be Uncoupled From Graft vs. Host Disease? An Examination of Proportions
by: Elizabeth Krieger, et al.
Published: (2020-04-01) -
Expression of Granulysin in Humanized Mouse Model System of Xenogeneic Graft-versus-Host-Disease
by: Yu-Ling Lan, et al.
Published: (2011) -
Graft versus host disease in the bone marrow, liver and thymus humanized mouse model.
by: Matthew B Greenblatt, et al.
Published: (2012-01-01) -
Graft-versus-host disease of the kidney
by: Abhilash Koratala, et al.
Published: (2020-09-01)